Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2010

01.08.2010

Same morphology of ventricular premature complexes triggering repeated ventricular fibrillation

verfasst von: Juan José Sánchez-Muñoz, Arcadio García-Alberola, Juan Martínez-Sánchez, Pablo Peñafiel-Verdú, César Caro-Martínez, Sergio Manzano-Fernández, Mariano Valdés-Chavarri

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Episodes ventricular fibrillation (VF) initiated by ventricular premature complexes (VPCs) of a single morphology have been reported. However, the characteristics of the VPCs over long periods of time are unknown.

Objectives

To compare the morphologies and coupling intervals of VPCs that initiate episodes of VF that occur at different time periods.

Methods

The database of the follow-up of the International Classification of Diseases (ICD) unit was reviewed and patients having at least two spontaneous VF episodes with available recorded EGMs in unipolar and bipolar configuration were included in the study. The coupling interval and morphology of the initiating beat were analyzed.

Results

Nine out of 300 patients with ICD had two or more spontaneous VF episodes. The time interval between episodes ranged from seconds (arrhythmic storm) to 3 years. The fibrillatory VPCs presented the same morphology in both recordings in all episodes of each patient. The coupling intervals of VPCs initiating VF were close for the episodes that occurred during a single arrhythmic storm and were more variable when the time intervals between episodes of VF were longer.

Conclusion

VPCs triggering VF that occur at different times in the same patient have similar morphologies suggesting similar sites of origin for the initial VPC of VF in each patient.
Literatur
1.
Zurück zum Zitat Haïssaguerre, M., Extramiana, F., Hocini, M., Cauchemez, B., Jaïs, P., & Cabrera, J. A. (2003). Mapping and ablation of ventricular fibrillation associated with long QT and Brugada syndromes. Circulation, 108, 925–928.CrossRefPubMed Haïssaguerre, M., Extramiana, F., Hocini, M., Cauchemez, B., Jaïs, P., & Cabrera, J. A. (2003). Mapping and ablation of ventricular fibrillation associated with long QT and Brugada syndromes. Circulation, 108, 925–928.CrossRefPubMed
2.
Zurück zum Zitat Haïssaguerre, M., Shah, D. C., Jaïs, P., Shoda, M., Kautzner, J., Arentz, T., et al. (2002). Role of Purkinje-conducting system in triggering of idiopathic ventricular fibrillation. Lancet, 359, 677–678.CrossRefPubMed Haïssaguerre, M., Shah, D. C., Jaïs, P., Shoda, M., Kautzner, J., Arentz, T., et al. (2002). Role of Purkinje-conducting system in triggering of idiopathic ventricular fibrillation. Lancet, 359, 677–678.CrossRefPubMed
3.
Zurück zum Zitat Okada, T., Yamada, T., Murakami, Y., Yoshida, N., Ninomiya, Y., & Toyama, J. (2007). Mapping and ablation of trigger premature ventricular contractions in a case of electrical storm associated with ischemic cardiomyopathy. PACE, 30, 440–443.PubMed Okada, T., Yamada, T., Murakami, Y., Yoshida, N., Ninomiya, Y., & Toyama, J. (2007). Mapping and ablation of trigger premature ventricular contractions in a case of electrical storm associated with ischemic cardiomyopathy. PACE, 30, 440–443.PubMed
4.
Zurück zum Zitat Haïssaguerre, M., Shoda, M., Jaïs, P., Nogami, A., Shah, D., & Kautzner, J. (2002). Mapping and ablation of idiopathic ventricular fibrillation. Circulation, 106, 962–967.CrossRefPubMed Haïssaguerre, M., Shoda, M., Jaïs, P., Nogami, A., Shah, D., & Kautzner, J. (2002). Mapping and ablation of idiopathic ventricular fibrillation. Circulation, 106, 962–967.CrossRefPubMed
5.
Zurück zum Zitat Bayés de Luna, A., Coumel, P., & Leclercq, J. F. (1989). Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. American Heart Journal, 117(1), 151–159.CrossRefPubMed Bayés de Luna, A., Coumel, P., & Leclercq, J. F. (1989). Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. American Heart Journal, 117(1), 151–159.CrossRefPubMed
6.
Zurück zum Zitat Kakishita, M., Kurita, T., Matsuo, K., Taguchi, A., Suyama, K., Shimizu, W., et al. (2000). Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. Journal of the American College of Cardiology, 36(5), 1646–1653.CrossRefPubMed Kakishita, M., Kurita, T., Matsuo, K., Taguchi, A., Suyama, K., Shimizu, W., et al. (2000). Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. Journal of the American College of Cardiology, 36(5), 1646–1653.CrossRefPubMed
7.
Zurück zum Zitat Marrouche, N. F., Verma, A., Wazni, O., Schweikert, R., Martin, D. O., & Saliba, W. (2004). Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. Journal of the American College of Cardiology, 43(9), 1715–1720.CrossRefPubMed Marrouche, N. F., Verma, A., Wazni, O., Schweikert, R., Martin, D. O., & Saliba, W. (2004). Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. Journal of the American College of Cardiology, 43(9), 1715–1720.CrossRefPubMed
8.
Zurück zum Zitat Szumowski, L., Sanders, P., Walczak, F., Hocini, M., Jaïs, P., Kepski, R., et al. (2004). Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. JACC, 44(8), 1700–1706.PubMed Szumowski, L., Sanders, P., Walczak, F., Hocini, M., Jaïs, P., Kepski, R., et al. (2004). Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. JACC, 44(8), 1700–1706.PubMed
9.
Zurück zum Zitat Morita, H., Fukushima-Kusano, K., Nagase, S., Takenaka-Morita, S., Nishii, N., Kakishita, M., et al. (2003). Site-specific arrhythmogenesis in patients with Brugada syndrome. Journal of Cardiovascular Electrophysiology, 14(4), 373–379.CrossRefPubMed Morita, H., Fukushima-Kusano, K., Nagase, S., Takenaka-Morita, S., Nishii, N., Kakishita, M., et al. (2003). Site-specific arrhythmogenesis in patients with Brugada syndrome. Journal of Cardiovascular Electrophysiology, 14(4), 373–379.CrossRefPubMed
10.
Zurück zum Zitat Almendral Garrote, J. M., Atienza, F., Rojo, J. L., Everss, E., Castilla, E., Gonzalez-Torrecilla, E., et al. (2008). Spatial resolution of ICD electrograms to identify different sites of left ventricular impulses. European Heart Journal, 29(1), 505.CrossRef Almendral Garrote, J. M., Atienza, F., Rojo, J. L., Everss, E., Castilla, E., Gonzalez-Torrecilla, E., et al. (2008). Spatial resolution of ICD electrograms to identify different sites of left ventricular impulses. European Heart Journal, 29(1), 505.CrossRef
Metadaten
Titel
Same morphology of ventricular premature complexes triggering repeated ventricular fibrillation
verfasst von
Juan José Sánchez-Muñoz
Arcadio García-Alberola
Juan Martínez-Sánchez
Pablo Peñafiel-Verdú
César Caro-Martínez
Sergio Manzano-Fernández
Mariano Valdés-Chavarri
Publikationsdatum
01.08.2010
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2010
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-010-9471-y

Weitere Artikel der Ausgabe 2/2010

Journal of Interventional Cardiac Electrophysiology 2/2010 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.